LinglingZZhiruD.The cause analysis and treatment suggestions of adverse reactions after human intravenous immunoglobulin (pH4) subcutaneous exudation. Int J Biol. 2021;44(4):202-205.
2.
DufficyMTakashimaMCunninghameJ, et al. Extravasation injury management for neonates and children: a systematic review and aggregated case series. J Hosp Med. 2022;17(10):832-842.
3.
HackenbergRKKabirKMüllerAHeydweillerABurgerCWelleK.Extravasation injuries of the limbs in neonates and children—development of a treatment algorithm. Dtsch Arztebl Int. 2021;118(33-34):547-554.
4.
DavidVChristouNEtienneP, et al. Extravasation of noncytotoxic drugs. Ann Pharmacother. 2020;54(8):804-814.
5.
SaghebSMohseniSOLamsehchiA.A new approach to skin extravasation injury management during the neonatal period. BMC Pediatr. 2022;22(1):451.
6.
KimJTParkJYLeeHJCheonYJ.Guidelines for the management of extravasation. J Educ Eval Health Prof. 2020;17:21.
7.
LeAPatelS.Extravasation of noncytotoxic drugs: a review of the literature. Ann Pharmacother. 2014;48(7):870-886.
8.
GopalakrishnanPNGoelNBanerjeeS.Saline irrigation for the management of skin extravasation injury in neonates. Cochrane Database Syst Rev. 2017;7:CD008404.
